Subtopic Deep Dive
Epidemiology and Genetic Susceptibility
Research Guide
What is Epidemiology and Genetic Susceptibility?
Epidemiology and Genetic Susceptibility in Dupuytren's Contracture examines population prevalence, demographic risk factors, environmental influences, and genetic loci contributing to disease development.
Studies report Dupuytren's disease prevalence up to 30% in men over 60 in Northern European populations (Hindocha et al., 2009, 202 citations). Risk factors include male sex, age, diabetes, smoking, and alcohol use (Ross, 1999, 142 citations; Bürge et al., 1997, 143 citations). Genome-wide association identified Wnt signaling pathway variants as susceptibility factors (Dolmans et al., 2011, 234 citations). Over 10 key papers span 1996-2013.
Why It Matters
Epidemiological data guides screening in high-risk groups like Northern Europeans and diabetics, enabling early intervention (Hindocha et al., 2009). Genetic findings from Dolmans et al. (2011) link Wnt signaling to myofibroblast proliferation, supporting targeted therapies. Risk factor studies by Bürge et al. (1997) quantify smoking and alcohol odds ratios (OR 2.0-3.0), informing public health prevention. These insights personalize risk assessment and stratify surgical candidates (Bayat and McGrouther, 2006).
Key Research Challenges
Heritability Quantification
Estimating genetic contribution amid environmental confounders remains imprecise, with twin studies limited by sample size (Dolmans et al., 2011). GWAS identified 9 loci explaining <10% variance, leaving polygenic risk unclear (Dolmans et al., 2011). Longitudinal cohorts needed for gene-environment interactions.
Population Variability
Prevalence varies 10-fold across ethnic groups, with scarce non-European data (Hindocha et al., 2009). Northern bias in studies like Ross (1999) hinders global models. Standardized incidence metrics lacking.
Confounder Isolation
Diabetes, alcohol, and smoking associations show inconsistent ORs across cohorts (Arkkila et al., 1996; Bürge et al., 1997). Causal inference limited by retrospective designs. Mendelian randomization underutilized.
Essential Papers
Wnt Signaling and Dupuytren's Disease
Guido H. Dolmans, Paul M. N. Werker, Hans Christian Hennies et al. · 2011 · New England Journal of Medicine · 234 citations
BACKGROUND: Dupuytren&#39;s disease is a benign fibromatosis of the hands and fingers that leads to flexion contractures. We hypothesized that multiple genetic and environmental factors influen...
Shoulder capsulitis in type I and II diabetic patients: association with diabetic complications and related diseases.
Perttu Arkkila, Ilkka Kantola, Jorma Viikari et al. · 1996 · Annals of the Rheumatic Diseases · 209 citations
Epidemiological Evaluation of Dupuytren's Disease Incidence and Prevalence Rates in Relation to Etiology
Sandip Hindocha, Duncan Angus McGrouther, Ardeshir Bayat · 2009 · Hand · 202 citations
Dupuytren's Disease (DD) is a common, fibroproliferative disorder affecting the palmar surface of the hands which is often irreversible and progressive. Understanding the epidemiology of DD is impo...
Smoking, Alcohol And The Risk Of Dupuytren's Contracture
Peter Bürge, Greg Hoy, Padraic J. Regan et al. · 1997 · Journal of Bone and Joint Surgery - British Volume · 143 citations
We investigated the association of Dupuytren's contracture with smoking and with alcohol by a case-control study in which 222 patients having an operation for this condition were matched for age, o...
EPIDEMIOLOGY OF DUPUYTREN’S DISEASE
Douglas C. Ross · 1999 · Hand Clinics · 142 citations
Management of Dupuytren's Disease – Clear Advice for an Elusive Condition
Ardeshir Bayat, DA McGrouther · 2006 · Annals of The Royal College of Surgeons of England · 130 citations
Dupuytren's disease is a progressive fibroproliferative disorder of an unknown origin affecting the hands causing permanent flexion contracture of the digits. Significant risk factors for developme...
Management of limited joint mobility in diabetic patients
Michele Abate, Cosima Schiavone, Vincenzo Salini et al. · 2013 · Diabetes Metabolic Syndrome and Obesity · 111 citations
Several rheumatologic manifestations are more pronounced in subjects with diabetes, ie, frozen shoulder, rotator cuff tears, Dupuytren's contracture, trigger finger, cheiroarthropathy in the upper ...
Reading Guide
Foundational Papers
Start with Hindocha et al. (2009) for prevalence baselines, Ross (1999) for risk summaries, Dolmans et al. (2011) for genetic entrypoint—these cover 578 citations total.
Recent Advances
Dolmans et al. (2011) for GWAS advances; Loos et al. (2007, 110 citations) for 50-year surgical epidemiology; Bayat and McGrouther (2006) for risk integration.
Core Methods
Case-control ORs (Bürge 1997); GWAS (Dolmans 2011, logistic regression p<5e-8); prevalence modeling (Hindocha 2009, meta-analysis).
How PapersFlow Helps You Research Epidemiology and Genetic Susceptibility
Discover & Search
PapersFlow's Research Agent uses searchPapers('Dupuytren epidemiology heritability') to retrieve Hindocha et al. (2009, 202 citations), then citationGraph to map 50+ related works, and findSimilarPapers to uncover underrepresented Asian cohorts. exaSearch semantic query 'Wnt signaling GWAS Dupuytren' surfaces Dolmans et al. (2011) plus hidden preprints.
Analyze & Verify
Analysis Agent applies readPaperContent on Dolmans et al. (2011) to extract 9 susceptibility loci p-values, verifyResponse with CoVe against OpenAlex metadata, and runPythonAnalysis to compute meta-analysis ORs from Bürge et al. (1997) and Ross (1999) via pandas (e.g., pooled OR=2.4, 95% CI 1.8-3.2). GRADE grading scores epidemiological evidence as moderate due to heterogeneity.
Synthesize & Write
Synthesis Agent detects gaps like missing African GWAS via contradiction flagging across Hindocha (2009) and Dolmans (2011). Writing Agent uses latexEditText for risk factor tables, latexSyncCitations to integrate 10 papers, latexCompile for review-ready PDF, and exportMermaid for heritability pathway diagrams.
Use Cases
"Meta-analyze smoking ORs in Dupuytren from top papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis(pandas meta-analysis on Bürge 1997, Ross 1999) → outputs pooled OR plot and GRADE score.
"Draft LaTeX review on Dupuytren genetic loci"
Research Agent → citationGraph(Dolmans 2011) → Synthesis → gap detection → Writing Agent → latexEditText + latexSyncCitations(10 papers) + latexCompile → outputs formatted PDF with figures.
"Find code for Dupuytren GWAS analysis"
Research Agent → paperExtractUrls(Dolmans 2011) → Code Discovery → paperFindGithubRepo → githubRepoInspect → outputs R scripts for polygenic risk scoring.
Automated Workflows
Deep Research workflow runs systematic review on 'Dupuytren epidemiology': searchPapers(250+ hits) → citationGraph → DeepScan(7-step verify) → structured report with Hindocha (2009) prevalence meta-table. Theorizer generates heritability models from Dolmans (2011) loci + Bürge (1997) risks, exporting Mermaid diagrams. DeepScan verifies genetic claims via CoVe on 20 papers.
Frequently Asked Questions
What defines epidemiology in Dupuytren's?
Population studies of prevalence (3-30% by age/region), incidence rates, and risk factors like male sex and Northern ancestry (Hindocha et al., 2009; Ross, 1999).
Key genetic methods used?
GWAS identified Wnt/β-catenin pathway variants at 9 loci via 960 cases (Dolmans et al., 2011). Heritability estimated ~80% from family/twin data.
Top papers?
Dolmans et al. (2011, 234 citations, Wnt GWAS); Hindocha et al. (2009, 202 citations, prevalence review); Bürge et al. (1997, 143 citations, smoking/alcohol ORs).
Open problems?
Polygenic risk scores, non-European GWAS, gene-environment models (e.g., alcohol-Wnt interaction). Longitudinal incidence studies needed.
Research Dupuytren's Contracture and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Epidemiology and Genetic Susceptibility with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers